BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38099328)

  • 1. A review of phase II and III drugs for the treatment and management of endometriosis.
    Perrone U; Evangelisti G; Laganà AS; Bogliolo S; Ceccaroni M; Izzotti A; Gustavino C; Ferrero S; Barra F
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):333-351. PubMed ID: 38099328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.
    Barra F; Grandi G; Tantari M; Scala C; Facchinetti F; Ferrero S
    Expert Opin Biol Ther; 2019 Apr; 19(4):343-360. PubMed ID: 30763525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging treatment options for endometriosis.
    Ferrero S; Evangelisti G; Barra F
    Expert Opin Pharmacother; 2018 Jul; 19(10):1109-1125. PubMed ID: 29975553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and Emerging Therapeutics for the Management of Endometriosis.
    Ferrero S; Barra F; Leone Roberti Maggiore U
    Drugs; 2018 Jul; 78(10):995-1012. PubMed ID: 29946962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pharmacotherapy in the treatment of endometriosis across the lifespan.
    Schwartz K; Llarena NC; Rehmer JM; Richards EG; Falcone T
    Expert Opin Pharmacother; 2020 Jun; 21(8):893-903. PubMed ID: 32164462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatments for endometriosis-associated pelvic pain.
    Zito G; Luppi S; Giolo E; Martinelli M; Venturin I; Di Lorenzo G; Ricci G
    Biomed Res Int; 2014; 2014():191967. PubMed ID: 25165691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pharmacological therapies for the treatment of endometriosis.
    Buggio L; Dridi D; Barbara G; Merli CEM; Cetera GE; Vercellini P
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1039-1052. PubMed ID: 36000243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the management of endometriosis-associated pain in France.
    Fernandez H; Agostini A; Baffet H; Chabbert-Buffet N; Descamps P; Estrade JP; Giraudet G; Hocke C; Salle B; Tremollieres F; Chapron C
    J Gynecol Obstet Hum Reprod; 2023 Nov; 52(9):102664. PubMed ID: 37669732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational drugs for the treatment of endometriosis, an update on recent developments.
    Barra F; Scala C; Mais V; Guerriero S; Ferrero S
    Expert Opin Investig Drugs; 2018 May; 27(5):445-458. PubMed ID: 29708812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].
    Legendre G; Delbos L; Hudon E; Chabbert-Buffet N; Geoffron S; Sauvan M; Fernandez H; Bouet PE; Descamps P
    Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):256-263. PubMed ID: 29530558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain.
    Barra F; Scala C; Ferrero S
    Drugs Today (Barc); 2019 Apr; 55(4):237-246. PubMed ID: 31050692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis?
    Donnez J; Dolmans MM
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in pharmacotherapy for treating endometriosis.
    Tafi E; Leone Roberti Maggiore U; Alessandri F; Bogliolo S; Gardella B; Vellone VG; Grillo F; Mastracci L; Ferrero S
    Expert Opin Pharmacother; 2015; 16(16):2465-83. PubMed ID: 26569155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pain associated with deep endometriosis: alternatives and evidence.
    Ferrero S; Alessandri F; Racca A; Leone Roberti Maggiore U
    Fertil Steril; 2015 Oct; 104(4):771-792. PubMed ID: 26363387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of medical treatments for endometriosis.
    Berlanda N; Somigliana E; Viganò P; Vercellini P
    Expert Opin Drug Saf; 2016 Jan; 15(1):21-30. PubMed ID: 26576479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of endometriosis: a systematic review.
    Schroder AK; Diedrich K; Ludwig M
    IDrugs; 2004 May; 7(5):451-63. PubMed ID: 15154107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel agents for the medical treatment of endometriosis.
    Platteeuw L; D'Hooghe T
    Curr Opin Obstet Gynecol; 2014 Aug; 26(4):243-52. PubMed ID: 24978852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of Linzagolix in the Management of Endometriosis, Including Design, Development and Potential Place in Therapy: A Narrative Review.
    Donnez J; Cacciottola L; Squifflet JL; Dolmans MM
    Drug Des Devel Ther; 2023; 17():369-380. PubMed ID: 36789095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal therapy for endometriosis: from molecular research to bedside.
    Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.